ATLAS fair value
₩62,380
Below fair value · 63% discount
Jw Pharmac stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Korea Exchange (KOSPI) · South Korea
Prices as of Oct 27, 2026 · KRW
₩62,380
Below fair value · 63% discount
49%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Jw Pharmac's fair value at about ₩62,380 per share (reasonable range: ₩43,851 to ₩88,740). At ₩23,150, the stock trades 63% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Jw Pharmac a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₩21,284 and ₩25,013; in 9 out of 10, between ₩18,446 and ₩28,861. Estimated annual volatility is 48%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Jw Pharmac sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 001060.KO has traded between ₩21,550 and ₩39,250. Today it is 41.0% below that high and 7% above its low.
On the business: net margin is 12.3%; it trades at 11.0 times earnings.
Its beta is 1.02: it moves roughly in line with the market.
JW Pharmaceutical Corporation manufactures and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cancer, immunological disease, cardiovascular system and metabolic diseases, regenerative medicine, eye diseases, and pancreatic cancer.
Want to see everything about Jw Pharmac?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About ₩62,380 per share according to ATLAS (reasonable range: ₩43,851 to ₩88,740). With the stock at ₩23,150, it is 63% below it.
49%: close to a coin flip. In half of the simulated outcomes, 001060.KO ends the month between ₩21,284 and ₩25,013.
Jw Pharmac's market capitalization is ₩546B. Its price-to-earnings (P/E) ratio is 11.0: you pay ₩11.0 for each ₩1.00 of yearly earnings.
Yes. 001060.KO's current dividend yield is 2.59% at today's price (₩23,150).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy